As expected, RRS enhanced anxiety in the elevated plus maze, decreased self-care behavior in the splash test, and decreased cortical glucocorticoid receptors levels; these alterations were prevented by daily treatment with the selective A<sub>2A</sub>R antagonist KW-6002 (3 mg/kg/day). The gene discussed is NR3C1; the disease is Anxiety.